Serum Institute of India

Named as a key player in 99 of our reports, across 33 regions and countries.

[1] ClinicalTrials.gov, Studies led by Serum Institute of India or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Serum Institute of India's markets

3

Markets where they are a key player. Each opens the market's statistics for every place we cover.

Pharmaceuticals3

Recent reports naming Serum Institute of India

Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.

All 99 reports

Companies they compete with most

Named as key players in the same markets as Serum Institute of India (number of shared markets).

Public data

Free public data on Serum Institute of India

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Home country
India
Type
Medicines

Source: Wikidata, Company record Q3480001. Retrieved 13 Nov 2026.

Trials over time

Studies Serum Institute of India leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Serum Institute of India or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Also active in

Markets we cover where free public records show Serum Institute of India: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Search all reports for Serum Institute of India All companies